POMALIDOMIDE for Systemic sclerosis pulmonary: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where POMALIDOMIDE was used for Systemic sclerosis pulmonary.
Most Reported Side Effects for POMALIDOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 7,023 | 7.6% | 3,048 | 1,311 |
| Death | 6,795 | 7.4% | 6,792 | 495 |
| Fatigue | 6,530 | 7.1% | 148 | 811 |
| Pneumonia | 5,792 | 6.3% | 653 | 4,576 |
| Off label use | 3,845 | 4.2% | 388 | 826 |
| Diarrhoea | 3,351 | 3.6% | 140 | 720 |
| White blood cell count decreased | 3,328 | 3.6% | 85 | 686 |
| Neutropenia | 3,029 | 3.3% | 386 | 944 |
| Rash | 2,715 | 2.9% | 47 | 273 |
| Dyspnoea | 2,543 | 2.8% | 145 | 890 |
| Neuropathy peripheral | 2,382 | 2.6% | 74 | 248 |
| Constipation | 2,374 | 2.6% | 52 | 334 |
| Asthenia | 2,300 | 2.5% | 117 | 715 |
| Nausea | 2,045 | 2.2% | 100 | 362 |
| Product dose omission issue | 1,961 | 2.1% | 7 | 174 |
Other Indications for POMALIDOMIDE
Plasma cell myeloma (81,096)
Product used for unknown indication (4,764)
Plasma cell myeloma recurrent (2,809)
Plasma cell myeloma refractory (1,562)
Plasma cell myeloma in remission (1,379)
Amyloidosis (477)
Off label use (434)
Kaposi's sarcoma (268)
Plasma cell leukaemia (209)
Plasmacytoma (191)
Other Drugs Used for Systemic sclerosis pulmonary
NINTEDANIB (214)
TOCILIZUMAB (89)
RITUXIMAB (25)
MYCOPHENOLATE MOFETIL (24)
TREPROSTINIL (22)
PIRFENIDONE (11)
CYCLOPHOSPHAMIDE (6)
PREDNISONE (5)